Full video transcriptClick to expand
Auto-generated transcript of @rhirhi2026's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00peptide-phradiHD keep watching. This is not medical advice. I am not a doctor.
- 0:06I'm just passionate about peptides and I like to learn about them.
- 0:09CMACs is a synthetic brain peptide developed in Russia. It's used clinically for stroke and cognitive disorders.
- 0:17Now you can inject or you can make a nasal spray or you can purchase nasal sprays.
- 0:22I personally make my own. Drop me a comment if you'd like a video on that because I have got one ready to go.
- 0:28Let me know if you want to see it. Some research suggests that it can help your brain learn, form new connections and focus.
- 0:36Do you have ADHD? Have you tried CMACs? Do you inject or do nasal? Let us know.
- 0:42Drop a comment, get the conversation going. CMACs, ADHD, just brain health in general. What do you think?
Nasal peptides for ADHD: separating signal from TikTok noise
Quick answer
Semax is a synthetic ACTH analog registered as a pharmaceutical drug in Russia, where it is prescribed for ischemic stroke and cognitive impairment under regulated clinical conditions. Its proposed mechanism involves BDNF and NGF upregulation, which has been observed in rodent studies, but no peer-reviewed randomized controlled trials exist specifically evaluating Semax for ADHD in human populations. The creator's framing of homemade nasal spray preparation sidesteps significant sterility and dosing concerns that apply to all compounded peptide products.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Nasal peptides for ADHD: separating signal from TikTok noise, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Nasal peptides for ADHD: separating signal from TikTok noise is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Nasal peptides for ADHD: separating signal from TikTok noise" from Rhirhi. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semax is a synthetic ACTH analog registered as a pharmaceutical drug in Russia, where it is prescribed for ischemic stroke and cognitive impairment under regulated clinical conditions.
The reason this review is not generic is the source wording and the canonical claim label "peptides adhd neurodivergent fyp nasal peppers." In this clip, the useful excerpt is: "peptide-phradiHD keep watching." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Semax is a synthetic ACTH analog registered as a pharmaceutical drug in Russia, where it is prescribed for ischemic stroke and cognitive impairment under regulated clinical conditions.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax is a synthetic ACTH analog registered as a pharmaceutical drug in Russia, where it is prescribed for ischemic stroke and cognitive impairment under regulated clinical conditions. Its proposed mechanism involves BDNF and NGF upregulation, which has been observed in rodent studies, but no peer-reviewed randomized controlled trials exist specifically evaluating Semax for ADHD in human populations. The creator's framing of homemade nasal spray preparation sidesteps significant sterility and dosing concerns that apply to all compounded peptide products.
- Semax has been a registered pharmaceutical drug in Russia since 1995, primarily for stroke recovery and cognitive impairment, not ADHD.
- A 2006 study by Dolotov et al. in the Journal of Neurochemistry found BDNF increases in rat hippocampus after intranasal Semax, but rat studies do not confirm human cognitive benefits.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax has been a registered pharmaceutical drug in Russia since 1995, primarily for stroke recovery and cognitive impairment, not ADHD.
- A 2006 study by Dolotov et al. in the Journal of Neurochemistry found BDNF increases in rat hippocampus after intranasal Semax, but rat studies do not confirm human cognitive benefits.
- No peer-reviewed randomized controlled trials have evaluated Semax specifically for ADHD symptoms in human subjects as of 2024.
- The FDA issued a 2021 safety communication flagging compounded peptide products for sterility risks. Home-prepared nasal sprays carry contamination and dosing hazards not addressed in this video.
- Nasal delivery of Semax is pharmacologically logical because peptides can bypass first-pass metabolism and reach the CNS more directly, but mechanism plausibility is not clinical proof of efficacy.
- Stimulant medications and behavioral therapies for ADHD have decades of randomized trial data across thousands of patients. Semax has no comparable evidence base for this indication.
- Anyone considering Semax or any compounded peptide should consult a licensed provider. Regulatory status varies by country, and in the US, Semax is not FDA-approved for any indication.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @rhirhi2026 actually say?
The creator is talking about Semax, a synthetic peptide developed in Russia, though they refer to it as "CMACs" throughout the video. They describe it as something used clinically for stroke and cognitive disorders, and they suggest it can help the brain "learn, form new connections and focus." They also mention making their own nasal spray at home and invite viewers with ADHD to share whether they inject or use nasal administration.
To their credit, they opened with a disclaimer that this is not medical advice. But the framing, asking ADHD viewers if they've "tried" Semax as a potential solution, does carry an implicit endorsement. That's worth keeping in mind as you read further.
Does the science back this up?
Some of it does, but the evidence base is thin and skewed toward animal models and small Russian clinical trials that have not been independently replicated in large Western studies.
Semax is a heptapeptide analog of ACTH(4-7) developed by the Institute of Molecular Genetics in Moscow. It has been registered in Russia as a nootropic drug since 1995 and is used clinically there for stroke, optic nerve disease, and cognitive impairment. The proposed mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), which are both relevant to synaptic plasticity and learning. A study by Dolotov et al. (2006, Journal of Neurochemistry) found that intranasal Semax increased BDNF levels in rat hippocampus. That is legitimately interesting. However, a rat hippocampus is not a human brain with ADHD, and we do not have randomized controlled trials in ADHD populations.
What did they get wrong (or right)?
They got the origin story basically right. Semax was indeed developed in Russia and has legitimate clinical use there for stroke and cognitive disorders. That is accurate. The claim that it can help your brain "learn, form new connections and focus" is plausible in theory but overstated as a practical benefit for a general audience.
What concerns me more is the casual mention of making a homemade nasal spray. Compounding peptides at home introduces real contamination and dosing risks. A 2021 FDA safety communication flagged compounded peptide products specifically for sterility concerns. There is also a meaningful difference between a pharmaceutical-grade Semax product manufactured under controlled conditions and something made in your kitchen. The creator does not address any of this, which is a meaningful omission for an audience that may take the DIY framing at face value.
The ADHD angle is the weakest part. There are no published clinical trials examining Semax specifically for ADHD. Linking a peptide with BDNF effects to ADHD because both involve attention is a logical leap that the current evidence does not support.
What should you actually know?
Semax is a real compound with a real research history, mostly from Russia and Eastern Europe. It is not a fringe supplement invented on a bodybuilding forum. But "has a research history" is not the same as "has proven efficacy for ADHD." Those are very different bars.
If you are managing ADHD, the treatments with the most rigorous evidence behind them are stimulant medications and behavioral therapies studied in thousands of patients over decades. Semax has been studied in dozens of patients, mostly for stroke recovery, mostly in one country. That asymmetry matters.
The nasal route is pharmacologically sensible for a peptide like Semax because it can bypass the blood-brain barrier more effectively than oral dosing. But "sensible mechanism" does not equal "safe to DIY." Anyone considering peptide use of any kind should be doing so under the supervision of a licensed provider who can assess individual risk, not based on a TikTok video, including this one.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rhirhi · TikTok creator
1.4K views on this video
#adhd #neurodivergent #fyp #nasal #peppers
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about semax has been a registered pharmaceutical drug in russia?
Semax has been a registered pharmaceutical drug in Russia since 1995, primarily for stroke recovery and cognitive impairment, not ADHD.
What does the video say about a 2006 study by dolotov et al. in the journal?
A 2006 study by Dolotov et al. in the Journal of Neurochemistry found BDNF increases in rat hippocampus after intranasal Semax, but rat studies do not confirm human cognitive benefits.
What does the video say about no peer-reviewed randomized controlled trials have evaluated semax specifically for?
No peer-reviewed randomized controlled trials have evaluated Semax specifically for ADHD symptoms in human subjects as of 2024.
What does the video say about the fda?
The FDA issued a 2021 safety communication flagging compounded peptide products for sterility risks. Home-prepared nasal sprays carry contamination and dosing hazards not addressed in this video.
What does the video say about nasal delivery of semax?
Nasal delivery of Semax is pharmacologically logical because peptides can bypass first-pass metabolism and reach the CNS more directly, but mechanism plausibility is not clinical proof of efficacy.
What does the video say about stimulant medications?
Stimulant medications and behavioral therapies for ADHD have decades of randomized trial data across thousands of patients. Semax has no comparable evidence base for this indication.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rhirhi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.